The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma.

Merih Kızıl ÇakarEmre TekgündüzMehmet S DalAlparslan MerdinSemih BaşçıDicle İskenderBilge UğurFiliz BekdemirJale YıldızBahar U UluMehmet BakırtaşTuğçe N YiğenoğluHikmetullah BatgiAli H KayaDicle İskenderFevzi Altuntaş

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

Our findings suggest that HDAC treatment followed by AHSCT seems to provide the best outcome for young-fit patients presenting with mantle cell lymphoma.

Keyphrases

high dose
acute myeloid leukemia
low dose
stem cell transplantation
bone marrow
cell therapy
mesenchymal stem cells
replacement therapy